Boston Scientific Corp. (BSX)
49.01
-1.36
(-2.70%)
USD |
NYSE |
Aug 24, 16:00
49.03
+0.02
(+0.04%)
After-Hours: 20:00
Boston Scientific Shareholders Equity (Quarterly) : 24.93B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.93B |
| March 31, 2026 | 25.86B |
| December 31, 2025 | 24.23B |
| September 30, 2025 | 23.39B |
| June 30, 2025 | 22.42B |
| March 31, 2025 | 22.21B |
| December 31, 2024 | 21.77B |
| September 30, 2024 | 20.71B |
| June 30, 2024 | 20.37B |
| March 31, 2024 | 19.93B |
| December 31, 2023 | 19.28B |
| September 30, 2023 | 18.89B |
| June 30, 2023 | 18.23B |
| March 31, 2023 | 17.85B |
| December 31, 2022 | 17.57B |
| September 30, 2022 | 17.64B |
| June 30, 2022 | 17.25B |
| March 31, 2022 | 16.74B |
| December 31, 2021 | 16.62B |
| September 30, 2021 | 16.46B |
| June 30, 2021 | 15.94B |
| March 31, 2021 | 15.72B |
| December 31, 2020 | 15.33B |
| September 30, 2020 | 15.56B |
| June 30, 2020 | 15.62B |
| Date | Value |
|---|---|
| March 31, 2020 | 13.80B |
| December 31, 2019 | 13.88B |
| September 30, 2019 | 9.699B |
| June 30, 2019 | 9.425B |
| March 31, 2019 | 9.233B |
| December 31, 2018 | 8.726B |
| September 30, 2018 | 8.289B |
| June 30, 2018 | 7.744B |
| March 31, 2018 | 7.03B |
| December 31, 2017 | 7.012B |
| September 30, 2017 | 7.588B |
| June 30, 2017 | 7.235B |
| March 31, 2017 | 7.053B |
| December 31, 2016 | 6.733B |
| September 30, 2016 | 6.482B |
| June 30, 2016 | 6.22B |
| March 31, 2016 | 6.457B |
| December 31, 2015 | 6.32B |
| September 30, 2015 | 6.41B |
| June 30, 2015 | 6.58B |
| March 31, 2015 | 6.501B |
| December 31, 2014 | 6.457B |
| September 30, 2014 | 6.701B |
| June 30, 2014 | 6.544B |
| March 31, 2014 | 6.534B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| Becton, Dickinson & Co. | 24.42B |
| Penumbra, Inc. | 1.531B |
| Insulet Corp. | 1.422B |
| Intuitive Surgical, Inc. | 18.17B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.22B |
| Total Liabilities (Quarterly) | 20.04B |
| Debt to Equity Ratio | 0.5064 |
| Current Ratio | 1.240 |
| Net Debt Paydown Yield | -0.30% |